Replies to post #332950 on Anavex Life Sciences Corp (AVXL)

[boi568]

There was a 2015 megastudy that concluded that 17 percent of trials fail between Phase 2 and Phase 3 due to safety issues.

[ignatiusrielly35]

Gotcha. Agreed. It all comes down to a dosage-safety/efficacy equation that comes from actual results.